These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 28640521)
1. PET/MRI for evaluating subclinical inflammation of ulcerative colitis. Shih IL; Wei SC; Yen RF; Chang CC; Ko CL; Lin BR; Shun CT; Liu KL; Wong JM; Chang YC J Magn Reson Imaging; 2018 Mar; 47(3):737-745. PubMed ID: 28640521 [TBL] [Abstract][Full Text] [Related]
2. Role of Positron Emission Tomography in Assessing Disease Activity in Ulcerative Colitis: Comparison with Biomarkers. Berry N; Sinha SK; Bhattacharya A; Prasad KK; Vaishnavi C; Vaiphei K; Samanta J; Prasada R; Dhaka N; Kochhar R Dig Dis Sci; 2018 Jun; 63(6):1541-1550. PubMed ID: 29564671 [TBL] [Abstract][Full Text] [Related]
3. Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole-body PET/MR: Correlation with pathological prognostic factors. Shih IL; Yen RF; Chen CA; Chen BB; Wei SY; Chang WC; Sheu BC; Cheng WF; Tseng YH; Chen XJ; Chen CH; Wei LH; Chiang YC; Torng PL; Yen ML; Shih TT J Magn Reson Imaging; 2015 Dec; 42(6):1723-32. PubMed ID: 25919115 [TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted magnetic resonance imaging without bowel preparation for detection of ulcerative colitis. Yu LL; Yang HS; Zhang BT; Lv ZW; Wang FR; Zhang CY; Chen WB; Zhang HM World J Gastroenterol; 2015 Sep; 21(33):9785-92. PubMed ID: 26361426 [TBL] [Abstract][Full Text] [Related]
5. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI. Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485 [TBL] [Abstract][Full Text] [Related]
6. Correlation of 18F-FDG PET/MRE Metrics with Inflammatory Biomarkers in Patients with Crohn's Disease: A Pilot Study. Domachevsky L; Leibovitzh H; Avni-Biron I; Lichtenstein L; Goldberg N; Nidam M; Groshar D; Bernstine H; Ben-Bassat O Contrast Media Mol Imaging; 2017; 2017():7167292. PubMed ID: 29097934 [TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT. Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China. Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660 [TBL] [Abstract][Full Text] [Related]
9. PET/CT colonography: a novel non-invasive technique for assessment of extent and activity of ulcerative colitis. Das CJ; Makharia GK; Kumar R; Kumar R; Tiwari RP; Sharma R; Malhotra A Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):714-21. PubMed ID: 20033154 [TBL] [Abstract][Full Text] [Related]
11. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [TBL] [Abstract][Full Text] [Related]
12. Intravoxel incoherent motion MRI in evaluating inflammatory activity in ulcerative colitis: a pilot study. Podgórska J; Pasicz K; Zagórowicz E; Mróz A; Gołębiewski B; Kuś P; Jasieniak J; Skrzyński W; Wieszczy P; Kukołowicz P; Cieszanowski A Acta Radiol; 2021 Apr; 62(4):439-446. PubMed ID: 32536258 [TBL] [Abstract][Full Text] [Related]
13. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET. Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481 [TBL] [Abstract][Full Text] [Related]
14. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis. Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous whole-body and breast 18F-FDG PET/MRI examinations in patients with breast cancer: a comparison of apparent diffusion coefficients and maximum standardized uptake values. Sasaki M; Tozaki M; Kubota K; Murakami W; Yotsumoto D; Sagara Y; Ohi Y; Oosako S; Sagara Y Jpn J Radiol; 2018 Feb; 36(2):122-133. PubMed ID: 29159779 [TBL] [Abstract][Full Text] [Related]
16. Disease activity and vascular involvement in retroperitoneal fibrosis: first experience with fully integrated 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging compared to clinical and laboratory parameters. Thuermel K; Einspieler I; Wolfram S; Moog P; Meier R; Schwaiger M; Heemann U Clin Exp Rheumatol; 2017; 35 Suppl 103(1):146-154. PubMed ID: 27974103 [TBL] [Abstract][Full Text] [Related]
18. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results. Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802 [TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography (PET) used to image subclinical inflammation associated with ulcerative colitis (UC) in remission. Rubin DT; Surma BL; Gavzy SJ; Schnell KM; Bunnag AP; Huo D; Appelbaum DE Inflamm Bowel Dis; 2009 May; 15(5):750-5. PubMed ID: 19090558 [TBL] [Abstract][Full Text] [Related]
20. Performance of Common Disease Activity Markers as a Reflection of Inflammatory Burden in Ulcerative Colitis. Brandse JF; Bennink RJ; van Eeden S; Löwenberg M; van den Brink GR; DʼHaens GR Inflamm Bowel Dis; 2016 Jun; 22(6):1384-90. PubMed ID: 26978724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]